Loading...
| A04049 | Pages: NA | Dec 2021 | 5529 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Whole Exome Sequencing Market
Request Now !Exome sequencing is a technique for sequencing all of the exome and protein-coding genes in a genome. This technique includes selection of the subset of DNA that encodes proteins or exons, followed by sequencing of the exonic DNA using high-throughput DNA sequencing methods. Exome sequencing is used to identify genetic variants responsible for diseases such as Miller Syndrome and Alzheimers disease.
The global whole exome sequencing market is driven by increase in number of R&D activities to fulfill new scientific applications, high adoption of advanced technologies, rise in awareness about whole exome sequencing technology, and high demand for diagnosis of rare diseases. However, lack of skilled professionals and ethical & legal issues associated with these techniques restrain the market growth. Furthermore, the high demand for personalized medicine and development of new innovative products by key players provide numerous opportunities for market expansion in the near future.
The whole exome sequencing market is segmented on the basis of product, technology, application, end user, and region. Based on product, it is divided into systems, kits, and services. Systems is further divided into Hiseq Series, Miseq, and ION torrent platforms. Hiseq series is further bifurcated into Hiseq 2500 and Hiseq 1500. ION torrent platforms is sub-divided into ION PGM and ION Proton. Kits are further sub-segmented into DNA fragmentation, end repair, A-Tailing, size selection kits, library preparation kits, and target enrichment kits. The services segment is divided into sequencing services and data analysis (bioinformatics) services. Based on technology, the market is categorized into sequencing by synthesis, ION semiconductor sequencing, and others. The application segment includes diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and others. Diagnostics application segment is further sub-segmented into cancer diagnostics, monogenic (Mendelian) disorders, monogenic types of diabetes, and others. On the basis of end user, the market is classified into hospitals, clinics, research centers, academic & government institutes, pharmaceutical & biotechnology companies, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the market include Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, F. Hoffmann-La Roche AG, Eurofins Scientific Group, GENEWIZ, Inc., Knome, Inc., Macrogen, Inc., Ambry Genetics Corp., and Beijing Genomics Institute.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 WHOLE EXOME SEQUENCING MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SYSTEMS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Hiseq Series
4.2.4.1. Market size and forecast
4.2.4.2. Hiseq 2500
4.2.4.2.1. Market size and forecast
4.2.4.3. Hiseq 1500
4.2.4.3.1. Market size and forecast
4.2.5. Miseq
4.2.5.1. Market size and forecast
4.2.6. ION Torrent Platforms
4.2.6.1. Market size and forecast
4.2.6.2. ION PGM
4.2.6.2.1. Market size and forecast
4.2.6.3. ION Proton
4.2.6.3.1. Market size and forecast
4.3. KITS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. DNA Fragmentation, End Repair, A-Tailing, and Size Selection Kits
4.3.4.1. Market size and forecast
4.3.5. Library Preparation Kits
4.3.5.1. Market size and forecast
4.3.6. Target Enrichment Kits
4.3.6.1. Market size and forecast
4.4. SERVICES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Sequencing Services
4.4.4.1. Market size and forecast
4.4.5. Data Analysis (Bioinformatics) Services
4.4.5.1. Market size and forecast
4.4.6. Other Services
4.4.6.1. Market size and forecast
CHAPTER 5 WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. SEQUENCING BY SYNTHESIS (SBS)
5.2.1. Market size and forecast
5.3. ION SEMICONDUCTOR SEQUENCING
5.3.1. Market size and forecast
5.4. OTHER TECHNOLOGIES
5.4.1. Market size and forecast
5.4.2. Sequencing by Ligation (SBL)
5.4.2.1. Market size and forecast
5.4.3. Pyrosequencing
5.4.3.1. Market size and forecast
CHAPTER 6 WHOLE EXOME SEQUENCING MARKET, BY APPLICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. DIAGNOSTICS
6.2.1. Market size and forecast
6.2.2. Cancer Diagnostics
6.2.2.1. Market size and forecast
6.2.3. Monogenic (Mendelian) Disorders
6.2.3.1. Market size and forecast
6.2.4. Monogenic Types of Diabetes
6.2.4.1. Market size and forecast
6.2.5. Others
6.2.5.1. Market size and forecast
6.2.5.2. Common Diseases and Complex Disorders
6.2.5.2.1. Market size and forecast
6.2.5.3. Movement Disorders
6.2.5.3.1. Market size and forecast
6.2.5.4. HIV
6.2.5.4.1. Market size and forecast
6.3. DRUG DISCOVERY AND DEVELOPMENT
6.3.1. Market size and forecast
6.4. PERSONALIZED MEDICINE
6.4.1. Market size and forecast
6.5. AGRICULTURE & ANIMAL RESEARCH
6.5.1. Market size and forecast
6.6. OTHERS
6.6.1. Market size and forecast
CHAPTER 7 WHOLE EXOME SEQUENCING MARKET, BY END USER
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. HOSPITALS
7.2.1. Market size and forecast
7.3. CLINICAL LABORATORIES
7.3.1. Market size and forecast
7.4. RESEARCH CENTERS
7.4.1. Market size and forecast
7.5. ACADEMIC & GOVERNMENT INSTITUTES
7.5.1. Market size and forecast
7.6. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
7.6.1. Market size and forecast
7.7. OTHERS
7.7.1. Market size and forecast
CHAPTER 8 WHOLE EXOME SEQUENCING MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast
8.2.4. North America Whole Exome Sequencing Market by Product
8.2.5. North America Whole Exome Sequencing Market by Technology
8.2.6. North America Whole Exome Sequencing Market by Application
8.2.7. North America Whole Exome Sequencing Market by End User
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.3.4. Europe Whole Exome Sequencing Market by Product
8.3.5. Europe Whole Exome Sequencing Market by Technology
8.3.6. Europe Whole Exome Sequencing Market by Application
8.3.7. Europe Whole Exome Sequencing Market by End User
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Rest of Asia-Pacific market size and forecast
8.4.4. Asia-Pacific Whole Exome Sequencing Market by Product
8.4.5. Asia-Pacific Whole Exome Sequencing Market by Technology
8.4.6. Asia-Pacific Whole Exome Sequencing Market by Application
8.4.7. Asia-Pacific Whole Exome Sequencing Market by End User
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. Saudi Arabia market size and forecast
8.5.3.3. South Africa market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
8.5.4. LAMEA Whole Exome Sequencing Market by Product
8.5.5. LAMEA Whole Exome Sequencing Market by Technology
8.5.6. LAMEA Whole Exome Sequencing Market by Application
8.5.7. LAMEA Whole Exome Sequencing Market by End User
CHAPTER 9 COMPANY PROFILES
9.1. ILLUMINA, INC.
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. THERMO FISHER SCIENTIFIC INC.
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. AGILENT TECHNOLOGIES
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. F. HOFFMANN-LA ROCHE AG
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. EUROFINS SCIENTIFIC GROUP
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. GENEWIZ, INC.
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. KNOME, INC.
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. MACROGEN, INC.
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. AMBRY GENETICS CORP.
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. BEIJING GENOMICS INSTITUTE
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
